Standout Papers
Immediate Impact
23 standout
Citing Papers
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
2025 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Works of Yabing Guo being referenced
Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): Final overall survival analysis of the phase 3 CARES-310 study.
2024
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
2023 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yabing Guo | 151 | 105 | 70 | 15 | 230 | |
| A. Forgione | 105 | 54 | 50 | 15 | 267 | |
| Joanne O’Rourke | 148 | 118 | 49 | 13 | 257 | |
| Cheng‐Qian Zhong | 132 | 70 | 44 | 20 | 262 | |
| Wen‐Bin Ding | 63 | 74 | 46 | 11 | 188 | |
| Manuel Delgado | 112 | 135 | 39 | 19 | 265 | |
| M.L. González-Diéguez | 133 | 126 | 25 | 17 | 199 | |
| Daniel Almquist | 102 | 101 | 166 | 18 | 292 | |
| Sophie Dominguez | 111 | 162 | 146 | 13 | 277 | |
| Jiali Chen | 83 | 48 | 54 | 10 | 185 | |
| Yangqing Huang | 87 | 121 | 109 | 21 | 273 |
All Works
Loading papers...